Trimetazidine
تریمتازیدین
❤️ Cardiovascular SystemMetabolic anti-anginal
Market / country: 🇮🇷 Iran
⚠️ Reference for this drug is not reliable
Dosing and information for this drug come from Iranian pharmacy websites (secondary sources) and have not been checked against the manufacturer's official leaflet or IFDA. Always check the leaflet in the box before prescribing.
Vastarel (IR)
🧮 Dose calculator
Angina pectoris · Regimen source: Darooyab Trimetazidine · موارد مصرف
🛡️ Safety & information
Formulations
- 20 mg tablet — tablet 🇮🇷 Iran Darooyab Trimetazidine · اشکال دارویی
- 35 mg tablet — tablet 🇮🇷 Iran Darooyab Trimetazidine · اشکال دارویی
👥 Special populations
- 🤰 PregnancyNo data
The source for this drug has no section for this group.
- 🤱 BreastfeedingNo data
The source for this drug has no section for this group.
- 👶 ChildrenNo data
The source for this drug has no section for this group.
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)❌ None
- DailyMed (FDA label)❌ None
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDC01EB15
- Darooyab (Iran)Trimetazidine
🇮🇷 Iran only Darooyab · G-1925/Trimetazidine
This product is on the Iranian market only and has no US/UK reference label.
- 13153 · TRIMETAZIDINE 20MG TAB · قرص تریمتازیدین ۲۰ میلیگرم
- 12115 · TRIMETAZIDINE 35MG TAB · قرص تریمتازیدین ۳۵ میلیگرم
- 10838 · TRIMETAZIDINE 55MG TAB · قرص تریمتازیدین ۵۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)❌ Not present
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab Trimetazidine · اشکال داروییDarooyab Trimetazidine · موارد مصرفDarooyab · G-1925/Trimetazidine
- Clinical review⚠ Unverified